Ligence Attracts €3 Million Investment
Ligence, a leader in echocardiography automation technology, has attracted €3 million in seed funding led by venture capital firm Simpact Ventures. This funding will drive Ligence’s expansion efforts as the company prepares for FDA clearance in early 2025, opening new opportunities to make high-quality cardiac diagnostics more accessible worldwide.
ESC Congress Recap by Dr. Arnas Karuzas | London, 2024
AI trends, atrial fibrillation and chronic coronary syndrome management guidelines: all in ESC Congress recap (London, 2024) by Dr. Arnas Karuzas.